Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
letter
. 2003 Nov;41(11):5347–5348. doi: 10.1128/JCM.41.11.5347-5348.2003

Towards “Molecular Esperanto” or the Tower of Babel? (The Need for Harmonization of Techniques for Genotyping Clinical Isolates of Pseudomonas aeruginosa Isolated from Patients with Cystic Fibrosis)

John E Moore 1,2,3,4,5,6,*, Colin E Goldsmith 1,2,3,4,5,6, J Stuart Elborn 1,2,3,4,5,6, Philip G Murphy 1,2,3,4,5,6, Peter H Gilligan 1,2,3,4,5,6, Séamus Fanning 1,2,3,4,5,6, Graham Hogg 1,2,3,4,5,6
PMCID: PMC262538  PMID: 14605202

We read with interest the letter of Armstrong et al. (D. Armstrong, S. Bell, M. Robinson, P. Bye, B. Rose, C. Harbour, C. Lee, H. Service, M. Nissen, M. Syrmis, and C. Wainwright, Letter, J. Clin. Microbiol. 41:2266-2267, 2003) describing the occurrence of a clonal type (pulsotype I) of Pseudomonas aeruginosa at five cystic fibrosis (CF) centers along the east coast of Australia. This letter strongly asserts that this clonal type has spread to CF patients, not from either the hospital or external environments, but by person-to-person transmission. This letter also describes some of the recent events that have led to advances in molecular typing techniques and thus to the identification of a dominant and hypertransmissible clonal strain of P. aeruginosa at several CF centers. What this letter also demonstrates to the CF microbiology community is that there is an urgent requirement for the standardization and harmonization of genotyping techniques, both nationally and internationally, where several methods presently exist for strain characterization (for a detailed review of P. aeruginosa typing, see reference 15).

Armstrong et al. (letter) cite several previous studies employing pulsed-field gel electrophoresis (PFGE) typing of P. aeruginosa. A methodological comparison highlighting technical variations in previous PFGE typing studies of P. aeruginosa is detailed in Table 1. Thus, Armstrong et al. were correct and diligent in comparing interlaboratory variability in deciding the relatedness of isolates from five CF centers, when more than one microbiology laboratory was involved in strain analysis.

TABLE 1.

Comparison of PFGE typing methodologies

Reference for method Reference for method modified Restriction enzyme(s) employed Electrophoresis parameters
1 7 SpeI 0.5-25 s, 20 h
3 30-60 s, 4 h, 6 V/cm
12 17 SpeI 5-35 s, 11°C, 24 h, 6 V/cm
14 13 SpeI 5-90 s, 24 h, 13°C
5 4 XbaI, SpeI 2-28 s, 20 h, 14°C at 200 V
9 NDa XbaI, SpeI ND
6 10 DraI, XbaI ND
16 ND SpeI 5.3-34.9 s, 14°C, 20 h at 100-130 mA, 6 V/cm
2 10 DraI, XbaI ND
18
11
8 10 DraI, XbaI 3-15 s, 5.6 V/cm
a

ND, not described.

Recently Jones et al. (9) have stressed the importance of microbiological surveillance through molecular fingerprinting, namely, PFGE typing, in order to ascertain the extent of cross-infection of P. aeruginosa among CF patients. PFGE is no longer a method solely restricted to epidemiological typing research studies, but is one which is now used in many clinical diagnostic laboratories to aid with routine epidemiological analysis. Laboratories which are introducing such techniques for the analysis of their P. aeruginosa subtypes should adopt protocols that will yield data for their isolates which can be compared with data from other CF centers. This strategy has been successfully applied for typing enteric bacterial pathogens through the PulseNet system (www.cdc.gov/pulsenet). The exchange of typing data obtained by employing standardized and harmonized methods, via an electronic medium, as has been developed recently by the ESF Network for Exchange of Microbial Typing Information (http://lists.nottingham.ac.uk/mailman/listinfo/enemti), would facilitate our understanding of the molecular epidemiology of P. aeruginosa in CF patient populations.

Consensus is thus needed in order to ascertain if such differences, for example, different suppliers of restriction enzymes, internal standards, pulse field parameters, etc., are significant or not. If the effects of such differences are not known, then a feasibility study involving several centers needs to be undertaken to resolve these technical anomalies, so that a robust method may be adopted by the CF microbiology community. If it felt that such a trial is unnecessary, then it will be a relatively easy task to define a consensus PFGE protocol that will gain widespread acceptance.

The real treasure to the CF microbiology community of adopting standardized and harmonized genotyping protocols such as PFGE is that it will allow us to identify transmissible types locally as well as globally and provide a basis for the examination of virulence in common genotypes. If we fail to attempt to learn a form of “molecular Esperanto” in terms of speaking a common language of harmonized and standardized methodology, we will potentially suffer, as befell the Israelites in Old Testament times with the Tower of Babel (Genesis 11), from misunderstanding. Indeed, if we cannot communicate with each other, we can hardly cooperate with each other.

REFERENCES

  • 1.Anthony, M., B. Rose, M. B. Pegler, M. Elkins, H. Service, K. Thamotharampillai, J. Watson, M. Robinson, P. Bye, J. Merlino, and C. Harbour. 2002. Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients. J. Clin. Microbiol. 40:2772-2778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bagge, N., O. Ciofu, L. T. Skovgaard, and N. Hoiby. 2000. Rapid development in vitro and in vivo of resistance to ceftazidime in biofilm-growing Pseudomonas aeruginosa due to chromosomal beta-lactamase. APMIS 108:589-600. [DOI] [PubMed] [Google Scholar]
  • 3.Barth, A. L., and T. L. Pitt. 1995. Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients. J. Clin. Microbiol. 33:2192-2194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Butler, S. L., C. J. Doherty, J. E. Hughes, J. W. Nelson, and J. R. Govan. 1995. Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? J. Clin. Microbiol. 33:1001-1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Cheng, K., R. L. Smyth, J. R. Govan, C. Doherty, C. Winstanley, N. Denning, D. P. Heaf, H. van Saene, and C. A. Hart. 1996. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 348:639-642. [DOI] [PubMed] [Google Scholar]
  • 6.Fluge, G., B. Ojeniyi, N. Hoiby, A. Digranes, O. Ciofu, E. Hunstad, O. C. Haanaes, and O. T. Storrosten. 2001. Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients. Clin. Microbiol. Infect. 7:238-243. [DOI] [PubMed] [Google Scholar]
  • 7.Grothues, D., and B. Tummler. 1991. New approaches in genome analysis by pulsed-field gel electrophoresis: application to the analysis of Pseudomonas species. Mol. Microbiol. 5:2763-2776. [DOI] [PubMed] [Google Scholar]
  • 8.Jalal, S., O. Ciofu, N. Hoiby, N. Gotoh, and B. Wretlind. 2000. Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob. Agents Chemother. 44:710-712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Jones, A. M., J. R. Govan, C. J. Doherty, M. E. Dodd, B. J. Isalska, T. N. Stanbridge, and A. K. Webb. 2001. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 358:557-558. [DOI] [PubMed] [Google Scholar]
  • 10.Ojeniyi, B., U. S. Petersen, and N. Hoiby. 1993. Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients. APMIS 101:168-175. [PubMed] [Google Scholar]
  • 11.Ojeniyi, B., N. Hoiby, and V. T. Rosdahl. 1991. Genome fingerprinting as a typing method used on polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients. APMIS 99:492-498. [PubMed] [Google Scholar]
  • 12.Pellegrino, F. L., L. M. Teixeira, M. D. Carvalho, G. Mda, S. Aranha Nouer, M. Pinto De Oliveira, J. L. Mello Sampaio, A. D'Avila Freitas, A. L. Ferreira, E. Amorim, L. Ede, L. W. Riley, and B. M. Moreira. 2002. Occurrence of a multidrug-resistant Pseudomonas aeruginosa clone in different hospitals in Rio de Janeiro, Brazil. J. Clin. Microbiol. 40:2420-2424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Pfaller, M. A., R. J. Hollis, and H. S. Sader. 1992. Chromosomal restriction fragment analysis by pulsed-field gel electrophoresis, p. 10.5.c.1-10.5.c.11. In H. D. Isenberg (ed.), Clinical microbiology procedures handbook. American Society for Microbiology, Washington, D.C.
  • 14.Silbert, S., A. L. Barth, and H. S. Sader. 2001. Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients. J. Clin. Microbiol. 39:3976-3981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Speert, D. P. 2002. Molecular epidemiology of Pseudomonas aeruginosa. Front. Biosci. 7:354-361. [DOI] [PubMed] [Google Scholar]
  • 16.Spencker, F. B., S. Haupt, M. C. Claros, S. Walter, T. Lietz, R. Schille, and A. C. Rodloff. 2000. Epidemiologic characterization of Pseudomonas aeruginosa in patients with cystic fibrosis. Clin. Microbiol. Infect. 6:600-607. [DOI] [PubMed] [Google Scholar]
  • 17.Teixeira, L. M., M. G. Carvalho, V. L. Merquior, A. G. Steigerwalt, D. J. Brenner, and R. R. Facklam. 1997. Phenotypic and genotypic characterization of Vagococcus fluvialis, including strains isolated from human sources. J. Clin. Microbiol. 35:2778-2781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES